XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
STOCK-BASED COMPENSATION PLANS (Tables)
3 Months Ended
Mar. 31, 2024
STOCK-BASED COMPENSATION PLANS  
Schedule of outstanding and exercisable number of options

    

    

Outstanding Number of Options

Exercisable Number of Options

(in thousands)

(in thousands)

Plan Category

 

  

 

  

2005 Stock Option Plan

 

1

1

2017 Stock Option Plan

 

341

341

Total

 

342

342

Schedule of stock-based compensation expenses recorded in the condensed consolidated statements of operations

The following summarizes stock-based compensation expenses recorded in the condensed consolidated statements of income (in thousands):

 

For the Three Months Ended March 31, 

 

    

2024

    

2023

    

Cost of Revenue

$

8

$

8

Sales and marketing expense

 

160

 

61

General, and administrative

566

238

Total stock-based compensation expense

$

734

$

307

Schedule of stock option activity under all equity compensation plans

Weighted-

Weighted-

Average

Aggregate

Number of 

Average

Remaining

Intrinsic

Shares

Exercise

Contractual

Value

    

(in thousands)

    

Price

    

Term (Years)

    

(in thousands)

Outstanding at December 31, 2023

 

349

$

1.82

4.12

$

3,163

Granted

 

$

 

Forfeited

$

Exercised

 

(7)

$

2.46

 

Outstanding at March 31, 2024

 

342

$

1.81

3.85

$

3,614

Exercisable at March 31, 2024

 

342

$

1.81

3.85

$

3,614

Schedule of restricted stock award activity under all equity compensation plans

Number of

Shares

 

Weighted Average

    

(in thousands)

    

Grant Date Fair Value

Outstanding at December 31, 2023

502

$

10.73

Granted

67

11.68

Forfeited

(3)

12.55

Vested

(65)

12.09

Outstanding at March 31, 2024

 

501

$

10.73